{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:23Z","timestamp":1786119323741,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/mop.0b013e32832925f9","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T07:43:18Z","timestamp":1242891798000},"page":"182-187","source":"Crossref","is-referenced-by-count":40,"title":["Antivascular endothelial growth factor for retinopathy of prematurity"],"prefix":"10.1097","volume":"21","author":[{"given":"Helen A","family":"Mintz-Hittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaapos.2007.02.012","article-title":"Incidence, progression and duration of retinopathy of prematurity in Hispanics and white non-Hispanic infants","volume":"11","author":"Eliason","year":"2007","journal-title":"Journal of AAPOS"},{"key":"R2-3-20210206","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/bmj.39555.670718.BE","article-title":"Survival of extreme premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5","volume":"336","author":"Field","year":"2008","journal-title":"BMJ"},{"key":"R3-3-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/01913913-20080501-12","article-title":"An epidemiological analysis of retinopathy of prematurity over ten years","volume":"45","author":"Giannantonio","year":"2008","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R4-3-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bjo.2007.126201","article-title":"Retinopathy of prematurity in the United States","volume":"92","author":"Lad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R5-3-20210206","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited.","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R6-3-20210206","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archopht.124.11.1669-c","article-title":"Standard image of plus disease in retinopathy of prematurity","volume":"124","author":"Capone","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R7-3-20210206","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajo.2008.04.012","article-title":"Retinopathy of prematurity management using single image vs multiimage telemedicine examinations","volume":"146","author":"Lajoie","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R8-3-20210206","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ophtha.2007.09.006","article-title":"Telemedical diagnosis of retinopathy of prematurity","volume":"115","author":"Scott","year":"2008","journal-title":"Ophthalmology"},{"key":"R9-3-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00417-008-0943-z","article-title":"Stanford university network for diagnosis of retinopathy of prematurity (SUNDROP): 18-month experience with telemedicine","volume":"247","author":"Silva","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-3-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajo.2008.05.010","article-title":"Progression and timing of treatment of zone I retinopathy of prematurity","volume":"146","author":"Soh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R11-3-20210206","first-page":"594","article-title":"Computer assisted quantification of vascular tortuosity in retinopathy of prematurity (an American Ophthalmological Society Thesis)","volume":"105","author":"Wallace","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R12-3-20210206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaapos.2007.11.022","article-title":"Agreement among pediatric ophthalmologists in diagnosing plus and preplus disease in retinopathy of prematurity","volume":"12","author":"Wallace","year":"2008","journal-title":"Journal of AAPOS"},{"key":"R13-3-20210206","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaapos.2008.02.012","article-title":"Retinopathy of prematurity care: patterns of care and workforce analysis","volume":"12","author":"Kemper","year":"2008","journal-title":"Journal of AAPOS"},{"key":"R14-3-20210206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.earlhumdev.2007.11.006","article-title":"Screening for retinopathy of prematurity","volume":"84","author":"O'Keefe","year":"2008","journal-title":"Early Hum Dev"},{"key":"R15-3-20210206","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaapos.2007.11.009","article-title":"Telemedicine screening for retinopathy of prematurity in developing countries using digital retinal images: a feasibility project","volume":"12","author":"Skalet","year":"2008","journal-title":"Journal of AAPOS"},{"key":"R16-3-20210206","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1167\/iovs.07-1353","article-title":"Computerized analysis of retinal vessel width and tortuosity in premature infants","volume":"49","author":"Wilson","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-3-20210206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of Prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"R18-3-20210206","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of \u03c9-3-polyunsaturated fatty acids reduces pathological angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat Med"},{"key":"R19-3-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"Journal of AAPOS"},{"key":"R20-3-20210206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","author":"Fauchere","year":"2008","journal-title":"Pediatrics"},{"key":"R21-3-20210206","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","article-title":"IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth","volume":"104","author":"Lofqvist","year":"2007","journal-title":"PNAS"},{"key":"R22-3-20210206","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjo.2007.128371","article-title":"VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity","volume":"92","author":"Pieh","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R23-3-20210206","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3928\/0191-3913-20070301-10","article-title":"Effect of diode laser retinal ablative therapy for threshold retinopathy of prematurity on the visual field: Results of Goldmann Perimetry at a mean age of 11 years","volume":"144","author":"McLoone","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R24-3-20210206","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2007.07.028","article-title":"Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age","volume":"115","author":"Quinn","year":"2008","journal-title":"Ophthalmology"},{"key":"R25-3-20210206","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmology"},{"key":"R26-3-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R27-3-20210206","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-Label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity","volume":"28","author":"Lalwani","year":"2008","journal-title":"Retina"},{"key":"R29-3-20210206","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusake","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R30-3-20210206","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"R31-3-20210206","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after intravitreal injection of bevacizumab for advanced retinopathy of prematurity","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R33-3-20210206","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-008-0865-9","article-title":"The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity","volume":"246","author":"Kwinta","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R34-3-20210206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmocokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R35-3-20210206","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R36-3-20210206","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"R37-3-20210206","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"key":"R38-3-20210206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0301-4738.29505","article-title":"Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity","volume":"55","author":"Shaw","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"R39-3-20210206","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/IAE.0b013e31817f2f15","article-title":"The risk for retinal detachment associated with hemorrhages pre and postlaser treatment in retinopathy of prematurity","volume":"28","author":"Kim","year":"2008","journal-title":"Retina"},{"key":"R40-3-20210206","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreal bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32832925f9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:09Z","timestamp":1786038849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200904000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32832925f9","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}